Loading…
AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells
Background and Objectives AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effec...
Saved in:
Published in: | Journal of surgical oncology 2012-11, Vol.106 (6), p.680-688 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03 |
---|---|
cites | cdi_FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03 |
container_end_page | 688 |
container_issue | 6 |
container_start_page | 680 |
container_title | Journal of surgical oncology |
container_volume | 106 |
creator | Yang, Weng-Lang Perillo, William Liou, Deanna Marambaud, Philippe Wang, Ping |
description | Background and Objectives
AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effect of compound C, a small molecule inhibitor of AMPK, on the proliferation of several human colorectal cancer cell lines with diverse characteristics.
Methods
Four human colorectal cancer cell lines (HCT116, DLD‐1, SW480, and KM12C) were treated with compound C. Cell viability was determined by MTS assay. Cell cycle prolife was analyzed by flow cytometry. Acidic vesicular organelles were detected by acridine orange staining. Protein levels were measured by western blotting.
Results
Compound C inhibited the growth of four cell lines in a dose‐dependent manner and caused G2/M arrest. Compound C increased sub‐G1 cell population and induced chromatin condensation and cleavage of PARP in HCT116 and KM12C cells, while it induced acidic vesicular formation and conversion of LC3‐I to autophagosome‐associated LC3‐II in DLD‐1 and SW480 cells. Survivin, an anti‐apoptotic protein, was down‐regulated in all cell lines treated with compound C.
Conclusions
Compound C induces apoptotic or autophagic death in colorectal cancer cells and the preferred death mode is cell type‐dependent. J. Surg. Oncol. 2012; 106:680–688. © 2012 Wiley Periodicals, Inc. |
doi_str_mv | 10.1002/jso.23184 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1113980650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1113980650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03</originalsourceid><addsrcrecordid>eNp1kUFv0zAYhi0EYmVw4A8gS1zGIdtnO7Hj41SxDugYCBBHy3Vs6pLEwU609cZPx223HZB2-mR9z_vos16EXhM4JQD0bJPCKWWkLp-gGQHJCwmyfopmeUeLUkg4Qi9S2gCAlLx8jo4o5aLklM_Q3_OrL5-w79d-5ccQsQndEKa-wXOcpmGINiWbsLFti4cYWu9s1KMPPV5tc6qZzP4RHNZDGMaQfMI6p_U0hmGtf-0gvJ463WdzG6I1o26x0b2xcW9NL9Ezp9tkX93NY_Tj4v33-WWxvF58mJ8vC8MkKQsnDC1rTWqnOa0bTkzpHOiGSFpZ5ogg1q6McU4DB1tCXToKgtuKAdRVA-wYnRy8-Rt_JptG1fm0u0D3NkxJEUKYrIFXO_Ttf-gmTLHP1ylSVVSAJBXL1LsDZWJIKVqnhug7HbeKgNrVonItal9LZt_cGadVZ5sH8r6HDJwdgBvf2u3jJvXx2_W9sjgkfBrt7UNCx9-KCyYq9fPzQi0vxUKwr1Qt2T8I06c0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552709153</pqid></control><display><type>article</type><title>AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Yang, Weng-Lang ; Perillo, William ; Liou, Deanna ; Marambaud, Philippe ; Wang, Ping</creator><creatorcontrib>Yang, Weng-Lang ; Perillo, William ; Liou, Deanna ; Marambaud, Philippe ; Wang, Ping</creatorcontrib><description>Background and Objectives
AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effect of compound C, a small molecule inhibitor of AMPK, on the proliferation of several human colorectal cancer cell lines with diverse characteristics.
Methods
Four human colorectal cancer cell lines (HCT116, DLD‐1, SW480, and KM12C) were treated with compound C. Cell viability was determined by MTS assay. Cell cycle prolife was analyzed by flow cytometry. Acidic vesicular organelles were detected by acridine orange staining. Protein levels were measured by western blotting.
Results
Compound C inhibited the growth of four cell lines in a dose‐dependent manner and caused G2/M arrest. Compound C increased sub‐G1 cell population and induced chromatin condensation and cleavage of PARP in HCT116 and KM12C cells, while it induced acidic vesicular formation and conversion of LC3‐I to autophagosome‐associated LC3‐II in DLD‐1 and SW480 cells. Survivin, an anti‐apoptotic protein, was down‐regulated in all cell lines treated with compound C.
Conclusions
Compound C induces apoptotic or autophagic death in colorectal cancer cells and the preferred death mode is cell type‐dependent. J. Surg. Oncol. 2012; 106:680–688. © 2012 Wiley Periodicals, Inc.</description><identifier>ISSN: 0022-4790</identifier><identifier>EISSN: 1096-9098</identifier><identifier>DOI: 10.1002/jso.23184</identifier><identifier>PMID: 22674626</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>AMP-Activated Protein Kinases - antagonists & inhibitors ; AMPK ; apoptosis ; Apoptosis - drug effects ; autophagy ; Autophagy - drug effects ; Cell Cycle - drug effects ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; colorectal cancer ; Colorectal Neoplasms - drug therapy ; Colorectal Neoplasms - pathology ; compound C ; Humans ; Pyrazoles - pharmacology ; Pyrimidines - pharmacology ; Tumor Suppressor Protein p53 - analysis</subject><ispartof>Journal of surgical oncology, 2012-11, Vol.106 (6), p.680-688</ispartof><rights>Copyright © 2012 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03</citedby><cites>FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22674626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Weng-Lang</creatorcontrib><creatorcontrib>Perillo, William</creatorcontrib><creatorcontrib>Liou, Deanna</creatorcontrib><creatorcontrib>Marambaud, Philippe</creatorcontrib><creatorcontrib>Wang, Ping</creatorcontrib><title>AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells</title><title>Journal of surgical oncology</title><addtitle>J. Surg. Oncol</addtitle><description>Background and Objectives
AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effect of compound C, a small molecule inhibitor of AMPK, on the proliferation of several human colorectal cancer cell lines with diverse characteristics.
Methods
Four human colorectal cancer cell lines (HCT116, DLD‐1, SW480, and KM12C) were treated with compound C. Cell viability was determined by MTS assay. Cell cycle prolife was analyzed by flow cytometry. Acidic vesicular organelles were detected by acridine orange staining. Protein levels were measured by western blotting.
Results
Compound C inhibited the growth of four cell lines in a dose‐dependent manner and caused G2/M arrest. Compound C increased sub‐G1 cell population and induced chromatin condensation and cleavage of PARP in HCT116 and KM12C cells, while it induced acidic vesicular formation and conversion of LC3‐I to autophagosome‐associated LC3‐II in DLD‐1 and SW480 cells. Survivin, an anti‐apoptotic protein, was down‐regulated in all cell lines treated with compound C.
Conclusions
Compound C induces apoptotic or autophagic death in colorectal cancer cells and the preferred death mode is cell type‐dependent. J. Surg. Oncol. 2012; 106:680–688. © 2012 Wiley Periodicals, Inc.</description><subject>AMP-Activated Protein Kinases - antagonists & inhibitors</subject><subject>AMPK</subject><subject>apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>autophagy</subject><subject>Autophagy - drug effects</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>colorectal cancer</subject><subject>Colorectal Neoplasms - drug therapy</subject><subject>Colorectal Neoplasms - pathology</subject><subject>compound C</subject><subject>Humans</subject><subject>Pyrazoles - pharmacology</subject><subject>Pyrimidines - pharmacology</subject><subject>Tumor Suppressor Protein p53 - analysis</subject><issn>0022-4790</issn><issn>1096-9098</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp1kUFv0zAYhi0EYmVw4A8gS1zGIdtnO7Hj41SxDugYCBBHy3Vs6pLEwU609cZPx223HZB2-mR9z_vos16EXhM4JQD0bJPCKWWkLp-gGQHJCwmyfopmeUeLUkg4Qi9S2gCAlLx8jo4o5aLklM_Q3_OrL5-w79d-5ccQsQndEKa-wXOcpmGINiWbsLFti4cYWu9s1KMPPV5tc6qZzP4RHNZDGMaQfMI6p_U0hmGtf-0gvJ463WdzG6I1o26x0b2xcW9NL9Ezp9tkX93NY_Tj4v33-WWxvF58mJ8vC8MkKQsnDC1rTWqnOa0bTkzpHOiGSFpZ5ogg1q6McU4DB1tCXToKgtuKAdRVA-wYnRy8-Rt_JptG1fm0u0D3NkxJEUKYrIFXO_Ttf-gmTLHP1ylSVVSAJBXL1LsDZWJIKVqnhug7HbeKgNrVonItal9LZt_cGadVZ5sH8r6HDJwdgBvf2u3jJvXx2_W9sjgkfBrt7UNCx9-KCyYq9fPzQi0vxUKwr1Qt2T8I06c0</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Yang, Weng-Lang</creator><creator>Perillo, William</creator><creator>Liou, Deanna</creator><creator>Marambaud, Philippe</creator><creator>Wang, Ping</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20121101</creationdate><title>AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells</title><author>Yang, Weng-Lang ; Perillo, William ; Liou, Deanna ; Marambaud, Philippe ; Wang, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>AMP-Activated Protein Kinases - antagonists & inhibitors</topic><topic>AMPK</topic><topic>apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>autophagy</topic><topic>Autophagy - drug effects</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>colorectal cancer</topic><topic>Colorectal Neoplasms - drug therapy</topic><topic>Colorectal Neoplasms - pathology</topic><topic>compound C</topic><topic>Humans</topic><topic>Pyrazoles - pharmacology</topic><topic>Pyrimidines - pharmacology</topic><topic>Tumor Suppressor Protein p53 - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Weng-Lang</creatorcontrib><creatorcontrib>Perillo, William</creatorcontrib><creatorcontrib>Liou, Deanna</creatorcontrib><creatorcontrib>Marambaud, Philippe</creatorcontrib><creatorcontrib>Wang, Ping</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Weng-Lang</au><au>Perillo, William</au><au>Liou, Deanna</au><au>Marambaud, Philippe</au><au>Wang, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells</atitle><jtitle>Journal of surgical oncology</jtitle><addtitle>J. Surg. Oncol</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>106</volume><issue>6</issue><spage>680</spage><epage>688</epage><pages>680-688</pages><issn>0022-4790</issn><eissn>1096-9098</eissn><abstract>Background and Objectives
AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effect of compound C, a small molecule inhibitor of AMPK, on the proliferation of several human colorectal cancer cell lines with diverse characteristics.
Methods
Four human colorectal cancer cell lines (HCT116, DLD‐1, SW480, and KM12C) were treated with compound C. Cell viability was determined by MTS assay. Cell cycle prolife was analyzed by flow cytometry. Acidic vesicular organelles were detected by acridine orange staining. Protein levels were measured by western blotting.
Results
Compound C inhibited the growth of four cell lines in a dose‐dependent manner and caused G2/M arrest. Compound C increased sub‐G1 cell population and induced chromatin condensation and cleavage of PARP in HCT116 and KM12C cells, while it induced acidic vesicular formation and conversion of LC3‐I to autophagosome‐associated LC3‐II in DLD‐1 and SW480 cells. Survivin, an anti‐apoptotic protein, was down‐regulated in all cell lines treated with compound C.
Conclusions
Compound C induces apoptotic or autophagic death in colorectal cancer cells and the preferred death mode is cell type‐dependent. J. Surg. Oncol. 2012; 106:680–688. © 2012 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>22674626</pmid><doi>10.1002/jso.23184</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-4790 |
ispartof | Journal of surgical oncology, 2012-11, Vol.106 (6), p.680-688 |
issn | 0022-4790 1096-9098 |
language | eng |
recordid | cdi_proquest_miscellaneous_1113980650 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | AMP-Activated Protein Kinases - antagonists & inhibitors AMPK apoptosis Apoptosis - drug effects autophagy Autophagy - drug effects Cell Cycle - drug effects Cell Line, Tumor Cell Proliferation - drug effects Cell Survival - drug effects colorectal cancer Colorectal Neoplasms - drug therapy Colorectal Neoplasms - pathology compound C Humans Pyrazoles - pharmacology Pyrimidines - pharmacology Tumor Suppressor Protein p53 - analysis |
title | AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A36%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AMPK%20inhibitor%20compound%20C%20suppresses%20cell%20proliferation%20by%20induction%20of%20apoptosis%20and%20autophagy%20in%20human%20colorectal%20cancer%20cells&rft.jtitle=Journal%20of%20surgical%20oncology&rft.au=Yang,%20Weng-Lang&rft.date=2012-11-01&rft.volume=106&rft.issue=6&rft.spage=680&rft.epage=688&rft.pages=680-688&rft.issn=0022-4790&rft.eissn=1096-9098&rft_id=info:doi/10.1002/jso.23184&rft_dat=%3Cproquest_cross%3E1113980650%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1552709153&rft_id=info:pmid/22674626&rfr_iscdi=true |